• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. TVT EXACT RETROPUBIC SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. TVT EXACT RETROPUBIC SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Model Number TVTRL
Device Problem Migration (4003)
Patient Problem Erosion (1750)
Event Date 04/01/2022
Event Type  Injury  
Event Description
It was reported that a patient underwent a gynecological procedure on (b)(6) 2021 and mesh was implanted.On (b)(6) 2022, mesh erosion was noted.The patient received unspecified drug therapy.The erosion has been reported as a causal relationship with the study procedure, but not related to the study device.The event has been recovered/resolved without sequelae as of (b)(6) 2022.Additional information was requested.
 
Manufacturer Narrative
(b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Please provide the site/location, symptoms and diagnostic confirmation of the mesh erosion noted on (b)(6) 2022.Describe the drug therapy provided for this mesh erosion including medication name and results.Was any surgical intervention performed? if so, please provide the date and findings.What is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status? to date it has been reported that the device will not be returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).A manufacturing record evaluation was performed for the finished device batch, and no non-conformances were identified.Related events captured via 2210968-2022-09423.
 
Manufacturer Narrative
(b)(4) this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested and the following was received: please provide the site/location, symptoms and diagnostic confirmation of the mesh erosion noted on 05/06/2022: patient had no symptoms, mesh erosion was detected by a speculum describe the drug therapy provided for this mesh erosion including medication name and results: patient had no therapy from (b)(6)2022 until (b)(6)2022.Local estrogenization was recommended using ovestin creme 1mg from (b)(6)2022 till (b)(6)2022 (once a day).Was any surgical intervention performed? if so, please provide the date and findings: no.What is the physician¿s opinion as to the etiology of or contributing factors to this event? lack of estrogenization of the vaginal epithelium and increased physical exercises what is the patient's current status?: patient has no complaints.Related events captured via 2210968-2022-07212 and 2210968-2022-09423.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TVT EXACT RETROPUBIC SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC. - NEUCHATEL
puits godet 20
neuchatel 2000
SZ   2000
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
9083863534
MDR Report Key15791362
MDR Text Key303630137
Report Number2210968-2022-09423
Device Sequence Number1
Product Code OTN
UDI-Device Identifier10705031062375
UDI-Public10705031062375
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K132054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberTVTRL
Device Catalogue NumberTVTRL
Device Lot Number3938802
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-